ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

ClinicalTrials.gov ID: NCT04633239

Public ClinicalTrials.gov record NCT04633239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer

Study identification

NCT ID
NCT04633239
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
42 participants

Conditions and interventions

Interventions

  • Abemaciclib Drug
  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Olaparib Drug

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1, 2021
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026
Last update posted
Apr 23, 2026

2021 – 2026

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 Active, not recruiting
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612 Recruiting
Los Angeles General Medical Center Los Angeles California 90033 Recruiting
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 Recruiting
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 Recruiting
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146 Active, not recruiting
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442 Active, not recruiting
Mayo Clinic in Florida Jacksonville Florida 32224-9980 Active, not recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 Active, not recruiting
UM Sylvester Comprehensive Cancer Center at Plantation Plantation Florida 33324 Active, not recruiting
Northwestern University Chicago Illinois 60611 Active, not recruiting
University of Kansas Clinical Research Center Fairway Kansas 66205 Recruiting
University of Kansas Cancer Center Kansas City Kansas 66160 Suspended
University of Kansas Cancer Center-Overland Park Overland Park Kansas 66210 Suspended
University of Kansas Hospital-Indian Creek Campus Overland Park Kansas 66211 Suspended
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205 Suspended
Mayo Clinic in Rochester Rochester Minnesota 55905 Recruiting
University of Kansas Cancer Center - North Kansas City Missouri 64154 Suspended
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 Suspended
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City Missouri 64116 Suspended
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 Terminated
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 Recruiting
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 Recruiting
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 Recruiting
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 Recruiting
University of Virginia Cancer Center Charlottesville Virginia 22908 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04633239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04633239 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →